RMD
ResMed·NYSE
--
--(--)
--
--(--)
8.10 / 10
Outperform
Sentiment scores 8.1 (Outperform) and fund‑flow 7.79 (good). Overall inflow ratio 0.48 but trend negative; small investors are net positive. Analyst consensus: 20% Strong Buy, 20% Buy, 60% Neutral, with most analysts showing 100% historical win rates. Outlook remains cautiously optimistic.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
20%
Buy
20%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-30
InstitutionPiper Sandler
Times predicted3
Historical Win Rate100.0%
What is the analyst consensus for RMD?
- RMD holds a Bullish analyst rating, with 20% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 8.10/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
